3. Campbell IM, Shaw CA, Stankiewicz P, Lupski JR. 2015; Somatic mosaicism: implications for disease and transmission genetics. Trends Genet. 31:382–92. DOI:
10.1016/j.tig.2015.03.013. PMID:
25910407. PMCID:
PMC4490042.
4. Huang AY, Xu X, Ye AY, Wu Q, Yan L, Zhao B, et al. 2014; Postzygotic single-nucleotide mosaicisms in whole-genome sequences of clinically unremarkable individuals. Cell Res. 24:1311–27. DOI:
10.1038/cr.2014.131. PMID:
25312340. PMCID:
PMC4220156.
7. Kurek KC, Luks VL, Ayturk UM, Alomari AI, Fishman SJ, Spencer SA, et al. 2012; Somatic mosaic activating mutations in
PIK3CA cause CLOVES syndrome. Am J Hum Genet. 90:1108–15. DOI:
10.1016/j.ajhg.2012.05.006. PMID:
22658544. PMCID:
PMC3370283.
8. Cao Y, Tokita MJ, Chen ES, Ghosh R, Chen T, Feng Y, et al. 2019; A clinical survey of mosaic single nucleotide variants in disease-causing genes detected by exome sequencing. Genome Med. 11:48. DOI:
10.1186/s13073-019-0658-2. PMID:
31349857. PMCID:
PMC6660700.
9. D'Gama AM, Woodworth MB, Hossain AA, Bizzotto S, Hatem NE, LaCoursiere CM, et al. 2017; Somatic mutations activating the mTOR pathway in dorsal telencephalic progenitors cause a continuum of cortical dysplasias. Cell Rep. 21:3754–66. DOI:
10.1016/j.celrep.2017.11.106. PMID:
29281825. PMCID:
PMC5752134.
10. Lim JS, Gopalappa R, Kim SH, Ramakrishna S, Lee M, Kim WI, et al. 2017; Somatic mutations in TSC1 and TSC2 cause focal cortical dysplasia. Am J Hum Genet. 100:454–72. DOI:
10.1016/j.ajhg.2017.01.030. PMID:
28215400. PMCID:
PMC5339289.
11. Perez D, Hsieh DT, Rohena L. 2017; Somatic mosaicism of
PCDH19 in a male with early infantile epileptic encephalopathy and review of the literature. Am J Med Genet A. 173:1625–30. DOI:
10.1002/ajmg.a.38233. PMID:
28462982.
13. Krupp DR, Barnard RA, Duffourd Y, Evans SA, Mulqueen RM, Bernier R, et al. 2017; Exonic mosaic mutations contribute risk for autism spectrum disorder. Am J Hum Genet. 101:369–90. DOI:
10.1016/j.ajhg.2017.07.016. PMID:
28867142. PMCID:
PMC5590950.
14. Dou Y, Yang X, Li Z, Wang S, Zhang Z, Ye AY, et al. 2017; Postzygotic single-nucleotide mosaicisms contribute to the etiology of autism spectrum disorder and autistic traits and the origin of mutations. Hum Mutat. 38:1002–13. DOI:
10.1002/humu.23255. PMID:
28503910. PMCID:
PMC5518181.
15. Wright CF, Prigmore E, Rajan D, Handsaker J, McRae J, Kaplanis J, et al. 2019; Clinically-relevant postzygotic mosaicism in parents and children with developmental disorders in trio exome sequencing data. Nat Commun. 10:2985. DOI:
10.1038/s41467-019-11059-2. PMID:
31278258. PMCID:
PMC6611863.
16. García-Romero MT, Parkin P, Lara-Corrales I. 2016; Mosaic neurofibromatosis type 1: a systematic review. Pediatr Dermatol. 33:9–17. DOI:
10.1111/pde.12673. PMID:
26338194.
17. Giannikou K, Lasseter KD, Grevelink JM, Tyburczy ME, Dies KA, Zhu Z, et al. 2019; Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission. Genet Med. 21:2639–43. DOI:
10.1038/s41436-019-0562-6. PMID:
31160751.
18. Cook CB, Armstrong L, Boerkoel CF, Clarke LA, du Souich C, Demos MK, et al. 2021; Somatic mosaicism detected by genome-wide sequencing in 500 parent-child trios with suspected genetic disease: clinical and genetic counseling implications. Cold Spring Harb Mol Case Stud. 7:a006125. DOI:
10.1101/mcs.a006125. PMID:
34697084. PMCID:
PMC8751411.
19. Aretz S, Stienen D, Friedrichs N, Stemmler S, Uhlhaas S, Rahner N, et al. 2007; Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP). Hum Mutat. 28:985–92. DOI:
10.1002/humu.20549. PMID:
17486639.
20. Hes FJ, Nielsen M, Bik EC, Konvalinka D, Wijnen JT, Bakker E, et al. 2008; Somatic
APC mosaicism: an underestimated cause of polyposis coli. Gut. 57:71–6. DOI:
10.1136/gut.2006.117796. PMID:
17604324.
21. Petrackova A, Vasinek M, Sedlarikova L, Dyskova T, Schneiderova P, Novosad T, et al. 2019; Standardization of sequencing coverage depth in NGS: recommendation for detection of clonal and subclonal mutations in cancer diagnostics. Front Oncol. 9:851. DOI:
10.3389/fonc.2019.00851. PMID:
31552176. PMCID:
PMC6738196.
22. Kinde I, Wu J, Papadopoulos N, Kinzler KW, Vogelstein B. 2011; Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci U S A. 108:9530–5. DOI:
10.1073/pnas.1105422108. PMID:
21586637. PMCID:
PMC3111315.
23. Hiatt JB, Pritchard CC, Salipante SJ, O'Roak BJ, Shendure J. 2013; Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation. Genome Res. 23:843–54. DOI:
10.1101/gr.147686.112. PMID:
23382536. PMCID:
PMC3638140.
24. Boyle EA, O'Roak BJ, Martin BK, Kumar A, Shendure J. 2014; MIPgen: optimized modeling and design of molecular inversion probes for targeted resequencing. Bioinformatics. 30:2670–2. DOI:
10.1093/bioinformatics/btu353. PMID:
24867941. PMCID:
PMC4155255.
25. MacConaill LE, Burns RT, Nag A, Coleman HA, Slevin MK, Giorda K, et al. 2018; Unique, dual-indexed sequencing adapters with UMIs effectively eliminate index cross-talk and significantly improve sensitivity of massively parallel sequencing. BMC Genomics. 19:30. DOI:
10.1186/s12864-017-4428-5. PMID:
29310587. PMCID:
PMC5759201.
26. Hirotsu Y, Otake S, Ohyama H, Amemiya K, Higuchi R, Oyama T, et al. 2020; Dual-molecular barcode sequencing detects rare variants in tumor and cell free DNA in plasma. Sci Rep. 10:3391. DOI:
10.1038/s41598-020-60361-3. PMID:
32099048. PMCID:
PMC7042261.
27. Yeom H, Lee Y, Ryu T, Noh J, Lee AC, Lee HB, et al. 2019; Barcode-free next-generation sequencing error validation for ultra-rare variant detection. Nat Commun. 10:977. DOI:
10.1038/s41467-019-08941-4. PMID:
30816127. PMCID:
PMC6395625.
28. Gambin T, Liu Q, Karolak JA, Grochowski CM, Xie NG, Wu LR, et al. 2020; Low-level parental somatic mosaic SNVs in exomes from a large cohort of trios with diverse suspected Mendelian conditions. Genet Med. 22:1768–76. DOI:
10.1038/s41436-020-0897-z. PMID:
32655138. PMCID:
PMC7606563.
29. Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. 2013; Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 31:213–9. DOI:
10.1038/nbt.2514. PMID:
23396013. PMCID:
PMC3833702.
30. Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, et al. 2012; VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22:568–76. DOI:
10.1101/gr.129684.111. PMID:
22300766. PMCID:
PMC3290792.
31. Yang X, Xu X, Breuss MW, Antaki D, Ball LL, Chung C, et al. 2023; Control-independent mosaic single nucleotide variant detection with DeepMosaic. Nat Biotechnol. 41:870–7. DOI:
10.1038/s41587-022-01559-w. PMID:
36593400. PMCID:
PMC10314968.
32. Dou Y, Kwon M, Rodin RE, Cortés-Ciriano I, Doan R, Luquette LJ, et al. 2020; Accurate detection of mosaic variants in sequencing data without matched controls. Nat Biotechnol. 38:314–9. DOI:
10.1038/s41587-019-0368-8. PMID:
31907404. PMCID:
PMC7065972.
33. Goriely A, Lord H, Lim J, Johnson D, Lester T, Firth HV, et al. 2010; Germline and somatic mosaicism for
FGFR2 mutation in the mother of a child with Crouzon syndrome: implications for genetic testing in "paternal age-effect" syndromes. Am J Med Genet A. 152A:2067–73. DOI:
10.1002/ajmg.a.33513. PMID:
20635358. PMCID:
PMC2988406.
34. Hyland VJ, Robertson SP, Flanagan S, Savarirayan R, Roscioli T, Masel J, et al. 2003; Somatic and germline mosaicism for a R248C missense mutation in
FGFR3, resulting in a skeletal dysplasia distinct from thanatophoric dysplasia. Am J Med Genet A. 120A:157–68. DOI:
10.1002/ajmg.a.20012. PMID:
12833394.
35. Taylor SA, Deugau KV, Lillicrap DP. 1991; Somatic mosaicism and female-to-female transmission in a kindred with hemophilia B (factor IX deficiency). Proc Natl Acad Sci U S A. 88:39–42. DOI:
10.1073/pnas.88.1.39. PMID:
1986380. PMCID:
PMC50743.
36. Costa JM, Vidaud D, Laurendeau I, Vidaud M, Fressinaud E, Moisan JP, et al. 2000; Somatic mosaicism and compound heterozygosity in female hemophilia B. Blood. 96:1585–7. DOI:
10.1182/blood.V96.4.1585. PMID:
10942410.
37. Leuer M, Oldenburg J, Lavergne JM, Ludwig M, Fregin A, Eigel A, et al. 2001; Somatic mosaicism in hemophilia A: a fairly common event. Am J Hum Genet. 69:75–87. DOI:
10.1086/321285. PMID:
11410838. PMCID:
PMC1226050.
38. Lemmers RJ, van der Wielen MJ, Bakker E, Padberg GW, Frants RR, van der Maarel SM. 2004; Somatic mosaicism in FSHD often goes undetected. Ann Neurol. 55:845–50. DOI:
10.1002/ana.20106. PMID:
15174019.
39. Buzhov BT, Lemmers RJ, Tournev I, van der Wielen MJ, Ishpekova B, Petkov R, et al. 2005; Recurrent somatic mosaicism for D4Z4 contractions in a family with facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 15:471–5. DOI:
10.1016/j.nmd.2005.03.005. PMID:
15935668.
40. Lim JS, Kim WI, Kang HC, Kim SH, Park AH, Park EK, et al. 2015; Brain somatic mutations in
MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med. 21:395–400. DOI:
10.1038/nm.3824. PMID:
25799227.
41. Møller RS, Weckhuysen S, Chipaux M, Marsan E, Taly V, Bebin EM, et al. 2016; Germline and somatic mutations in the
MTOR gene in focal cortical dysplasia and epilepsy. Neurol Genet. 2:e118. DOI:
10.1212/NXG.0000000000000118. PMID:
27830187. PMCID:
PMC5089441.
42. Lalonde E, Ebrahimzadeh J, Rafferty K, Richards-Yutz J, Grant R, Toorens E, et al. 2019; Molecular diagnosis of somatic overgrowth conditions: a single-center experience. Mol Genet Genomic Med. 7:e536. DOI:
10.1002/mgg3.536. PMID:
30761771. PMCID:
PMC6418364.
43. Lindhurst MJ, Sapp JC, Teer JK, Johnston JJ, Finn EM, Peters K, et al. 2011; A mosaic activating mutation in
AKT1 associated with the Proteus syndrome. N Engl J Med. 365:611–9. DOI:
10.1056/NEJMoa1104017. PMID:
21793738. PMCID:
PMC3170413.
44. Wieland I, Tinschert S, Zenker M. 2013; High-level somatic mosaicism of
AKT1 c.49G>A mutation in skin scrapings from epidermal nevi enables non-invasive molecular diagnosis in patients with Proteus syndrome. Am J Med Genet A. 161A:889–91. DOI:
10.1002/ajmg.a.35764. PMID:
23436452.
45. Hildebrand MS, Harvey AS, Malone S, Damiano JA, Do H, Ye Z, et al. 2018; Somatic
GNAQ mutation in the
forme fruste of Sturge-Weber syndrome. Neurol Genet. 4:e236. DOI:
10.1212/NXG.0000000000000236. PMID:
29725622. PMCID:
PMC5931068.
46. Tyburczy ME, Dies KA, Glass J, Camposano S, Chekaluk Y, Thorner AR, et al. 2015; Mosaic and intronic mutations in
TSC1/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing. PLoS Genet. 11:e1005637. DOI:
10.1371/journal.pgen.1005637. PMID:
26540169. PMCID:
PMC4634999.